x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Plenary Session - inactive due to federal service

Vinay Prasad, MD MPH

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail

science & medicine medicine

All Episodes

01:13:04

Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise &...

Plenary Session - inactive due to federal service ·

2023/04/12

Zeb joins me for the 7th time to discuss all the key pandemic questions

en

00:57:38

Harvard-MIT Center for Reg. Science Lecture (4-4-23)...

Plenary Session - inactive due to federal service ·

2023/04/05

My lecture to Harvard regulatory science

en

00:48:52

5.47 - Real World Evidence - Keynote Lecture in Denmark

Plenary Session - inactive due to federal service ·

2023/03/26

VP goes to Denmark to give the keynote at the Danish medical association conference

en

00:29:40

5.46 - What is Science: reflections on the field

Plenary Session - inactive due to federal service ·

2023/03/10

What is science?

en

01:52:18

5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care

Plenary Session - inactive due to federal service ·

2023/03/07

Karmma 3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor

en

00:42:41

More basics on randomized controlled trials - Part 2

Plenary Session - inactive due to federal service ·

2023/03/02

I get into endpoints, surrogates, validation, blinding, crossover, and control arms.

en

01:10:25

RCT 101 And Papa Heme

Plenary Session - inactive due to federal service ·

2023/02/28

I talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more. Then Papa Heme Tells you How to Find your First Job

en

00:56:48

Tom Newman And VP Discuss Public Health

Plenary Session - inactive due to federal service ·

2023/02/22

Dr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time.

en

01:07:24

5.41 - Michael Putman MCW debates me on recent policy Qs

Plenary Session - inactive due to federal service ·

2023/02/16

Mike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more.

en

00:53:41

Sensible Med Superbowl Plenary Session Crossover

Plenary Session - inactive due to federal service ·

2023/02/13

A new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer

en

00:44:56

5.39 - Sotorasib and Codebreak 200

Plenary Session - inactive due to federal service ·

2023/02/10

I destroy the trial. Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can.

en

00:42:08

Myeloma Twitter Just Makes Things Up - Lessons for...

Plenary Session - inactive due to federal service ·

2023/01/22

I annotate an online case discussion; Every decision is not based in evidence. Madness

en

00:40:10

5.37 - Keynote Lecture on Physician Burnout

Plenary Session - inactive due to federal service ·

2023/01/15

This lecture on Burnout will not be like any other you have heard

en

00:22:02

5.36 - ASH UPDATE #4 - GEM CESAR

Plenary Session - inactive due to federal service ·

2022/12/30

I break down the GEM CESAR trial K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer What a crazy trial!

en

00:19:14

5.35 - ASH Update #3 - the Ascent Trial

Plenary Session - inactive due to federal service ·

2022/12/29

This uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative. Sad day for oncology

en

00:21:37

5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs...

Plenary Session - inactive due to federal service ·

2022/12/24

Sample size games, primary endpoint, head to head trials in oncology Rate this podcast on itunes Coming next is Triangle trial

en

00:47:59

5.33 USC Grand Rounds Hematology

Plenary Session - inactive due to federal service ·

2022/12/23

Grand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed) More ASH coming soon

en

00:17:48

5.32 - ASH Update #1 - Talquetamab NEJM

Plenary Session - inactive due to federal service ·

2022/12/11

Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.

en

00:55:13

5.31 - MUST LISTEN Grand Rounds - COVID19 Updates

Plenary Session - inactive due to federal service ·

2022/12/08

In this lecture given December 7, 2022, I cover 5 things: Vaccines Masking Long COVID Schools/Immunity Debt Paxlovid

en

00:40:32

5.30 Rajkumar vs Goodman; Long COVID vs Long URI

Plenary Session - inactive due to federal service ·

2022/12/03

Should we treat smoldering MM, a debate Long COVID vs Long URI Review the show; Say Hi at ASH22

en

382 results

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe